Brain abnormalities in a Brazilian cohort

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 1, 2008, Pages 1-4

  Bichuetti, Denis Bernardi ^a,b   Rivero, René Leandro Magalhães ^a   Oliveira, Daniel May ^a   De Souza, Nilton Amorin ^a   Abdala, Nitamar ^a   Oliveira, Enedina Maria Lobato ^a   Gabbai, Alberto Alain ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Brain abnormalities; MRI; Neuromyelitis optica

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GADOLINIUM; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; BRAZIL; CAPSULA INTERNA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORPUS CALLOSUM; DIENCEPHALON; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; MAINTENANCE THERAPY; MALE; MESENCEPHALON; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OPTIC NEURITIS; RECURRENT DISEASE; SPINAL CORD; WHITE MATTER; ADOLESCENT; BRAIN; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES;

EID: 42049084003     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000100001     Document Type: Article

References (22)

1. Wingerchuk DM. Neuromyelitis optica. Int MS J 2006;13:42-50.
2. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114.
3. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002;125:1450-1461.
4. Assis JL, Maffei WE. Mielite neuro-óptica. Arq Neuropsiquiatr 1945;3:225-233.
5. Assis JL, Aidar O, Lombardi J. Mielopatia neuro-óptica. Artério e arteriolosclerose: considerações a propósito de um caso anatomo-clínico. Arq Neuropsiquiatr 1951;9:157-170.
6. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-846.
7. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study: I. Clinical course and disability. Brain 1989;112(Pt 1):133-146.
8. Cendrowski W. [Nuclear magnetic resonance in multiple sclerosis]. Pol Tyg Lek 1986;41:794-796.
9. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998;51:1219-1220.
10. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002;73:429-435.
11. Domingues RB, Kuster GW, Lanes F, Callegaro D. Recurrent neuromyelitis optica with diffuse central nervous system involvement: case report. Arq Neuropsiquiatr 2004;62:543-546.
12. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2012.
13. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-477.
14. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-396.
15. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006;77:1073-1075.
16. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964-968.
17. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
18. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003;60:848-853.
19. Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG. The natural history of recurrent optic neuritis. Arch Neurol 2004;61:1401-1405.
20. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002;58:143-146.
21. Weinshenker BG. Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system. J Clin Apher 1999;14:144-148.
22. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005;64:1270-1272.